13 min listen
Outlook For Biotech Sector
FromSchwab Network
ratings:
Length:
6 minutes
Released:
Apr 9, 2021
Format:
Podcast episode
Description
Brad Loncar says that some of the headwinds facing the biotech sector are FTC scrutiny of mergers, drug pricing legislation, strict FDA reviews, and rising interest rates. He recommends that investors look to diversify biotech investing outside of the U.S.
Released:
Apr 9, 2021
Format:
Podcast episode
Titles in the series (100)
The Latest Market Corrections by Schwab Network